This section is not available in the published analysis.
Rhegen: Audience
Rhegen is a biotechnology company focused on developing mRNA and nucleic acid-based biomedical products and therapies. The company possesses a comprehensive mRNA technology platform and unique foundational technologies, supported by multiple core patents.